Loading clinical trials...
Loading clinical trials...
Pilot Study With Bortezomib in Combination With Rituximab Standard Therapy in Patients With Relapsed or Refractory Follicular Lymphoma and at Least 2 Previous Therapies
Conditions
Interventions
Bortezomib
Rituximab
Locations
3
Germany
Kiel, Germany
Regensburg, Germany
Stuttgart, Germany
Start Date
February 1, 2006
Primary Completion Date
August 1, 2007
Completion Date
August 1, 2007
Last Updated
April 1, 2014
NCT06785818
NCT04911478
NCT06425302
NCT02278796
NCT00081809
NCT02376699
Lead Sponsor
Janssen-Cilag G.m.b.H
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions